Pfizer (PFE) EBT (2009 - 2026)
Pfizer (PFE) posted quarterly EBT of $3.2 billion for Q1 2026, up 13.82% year-over-year from $2.8 billion in Q1 2025, and up 293.06% quarter-over-quarter from -$1.6 billion in Q4 2025.
Pfizer (PFE) EBT (2009 - 2026) Analysis & Trends
Pfizer (PFE) has reported EBT for 18 consecutive years, with $3.2 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT rose 13.82% year-over-year to $3.2 billion; the TTM figure through Mar 2026 stood at $7.9 billion (down 44.07% YoY), while the FY2025 annual figure was $7.5 billion, down 6.27% from the prior year.
- EBT advanced to $3.2 billion in Q1 2026 per PFE's latest filing, from -$1.6 billion in the prior quarter.
- Across five years, EBT topped out at $11.4 billion in Q3 2022 and bottomed at -$4.1 billion in Q4 2023.
- Historically, EBT has averaged $3.6 billion across 5 years, with a median of $3.2 billion in 2026.
- Annual changes were most pronounced in 2024 — EBT sank 104.54% — and 2025, when it soared 3055.34%.
- Pfizer's EBT stood at $11.4 billion in 2022, then slumped by 136.07% to -$4.1 billion in 2023, then jumped by 294.55% to $8.0 billion in 2024, then sank by 120.44% to -$1.6 billion in 2025, then jumped by 293.06% to $3.2 billion in 2026.
- Business Quant data shows PFE's EBT at $3.2 billion in Q1 2026, -$1.6 billion in Q4 2025, and $3.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 474.95 Mn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 17.19 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | -653.00 Mn |
| Mar 29, 2026 | 3.17 Bn |
| Dec 31, 2025 | -1.64 Bn |
| Sep 28, 2025 | 3.33 Bn |
| Jun 29, 2025 | 3.04 Bn |
| Mar 30, 2025 | 2.79 Bn |
| Sep 29, 2024 | 8.03 Bn |
| Jun 30, 2024 | -103.00 Mn |
| Mar 31, 2024 | 3.42 Bn |
| Dec 31, 2023 | -4.13 Bn |
| Jul 2, 2023 | 2.27 Bn |
| Apr 2, 2023 | 6.27 Bn |
| Jul 3, 2022 | 11.45 Bn |
| Apr 3, 2022 | 9.05 Bn |
| Oct 3, 2021 | 20.48 Bn |
| Jul 4, 2021 | 6.95 Bn |
| Apr 4, 2021 | 5.69 Bn |
| Sep 27, 2020 | 6.44 Bn |
| Jun 28, 2020 | 3.03 Bn |
| Mar 29, 2020 | 2.84 Bn |